AYA vs EYE

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

AYA

ARTRYA FPO [AYA]

55MEDIUM

EYE

NOVA EYE FPO [EYE]

57MEDIUM

Score Breakdown

AYA EYE
Technical
62
57
Catalyst
57
53
Sentiment
50
50
Fundamental
90
76
Momentum
80
39
Risk Gate
50
45

Key Metrics

AYA Metric EYE
$924.2MMarket Cap$32.8M
801KAvg Volume (20d)269K
+0.9%Short InterestN/A
$6.49052-Week High$0.205
$0.86552-Week Low$0.100
+1.2%Daily Change+0.0%
$5.720Reference Price$0.115
-37.9%ROE-42.4%
N/AProfit Margin-21.3%

Active Signals

AYA Signals

●MACD momentum is losing steam
●Stochastic just turned bullish from a low level — early reversal sign
●Beating the Small Ords index — relative strength of 1.31, so it's outpacing the pack
●Trading above the 200-day average — the long-term trend is on your side
●Strong cash runway (15 quarters)
●Very high P/S ratio (31868.8x)
●Moderate revenue growth (+8%)
●EPS estimates revised upward (+10pts)

EYE Signals

●MACD momentum is picking up steam
●Stochastic is stretched into overbought — could need a breather
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Below the 200-day average — the long-term trend is still working against it
●Low cash runway (2 quarters) - dilution risk
●Low P/S ratio (1.0x)
●Strong revenue growth (+29%)
●EPS estimates revised upward (+10pts)

Ask Scout AI to compare AYA and EYE in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

AYA vs IDT →AYA vs LDX →AYA vs MAP →AYA vs NEU →AYA vs NTI →
AYA Full Analysis → EYE Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).